A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Follow-up report View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1995-06

AUTHORS

Glenn Steele, Robert J. Mayer, Anne Lindblad

ABSTRACT

Single institution studies of hepatic resection have implied that some subsets of patients with metastases from colon and rectum adenocarcinoma can be cured by surgery. However, it is unknown how such patients can be selected and what, in fact, the ultimate cure rate is. The objective of this multi-institutional study was to define in a prospective manner how many patients predicted to have resectable liver metastases actually could undergo curative resection and what the disease-free and overall survival were. A prospective 15-institution treatment plan included all patients who were predicted to have resectable metastases from colon and rectum cancer primaries. Results were compared among patients who underwent successful resection, patients who underwent resection with pathologically defined inadequate margins, and patients who underwent exploration but were found at surgery not to have resectable liver metastases. Fourteen institutions throughout North America and one in Milan who were members of the Gastrointestinal Tumor Study Group at the inception of this protocol in July of 1984 participated in the study. The patient population consisted of all those with metachronous or synchronous metastases from colon or rectum adenocarcinoma seen during a consecutive 3 1/2 year period with protocol registry at the time liver metastases were predicted to be isolated and resectable. Intervention consisted of the application of standard preoperative screening tests, abdominal exploration, and resection of all patients who had liver-only surgically resectable disease. The main outcome measures were: Accuracy of preoperative staging, acute and chronic operative morbidity, and disease-free, as well as overall, survival among the three treatment groups. The minimum follow up on all surviving patiens after curative resection was 2.2 years, with a median follow up of 3.2 years. Median survival times for patients receiving curative and noncurative resections and for those receiving no resection were estimated to be 35.7, 21.2, and 16.5 months, respectively. No statistically significant difference in the survival distribution of the noncuratively resected or the non-resected patients was observed. The survival distribution of curatively resected patients remains statistically superior to the distribution of noncuratively resected patients and those receiving no resection (P=0.01). These results confirmed that, although liver resection for hepatic metastases from colorectal car cinoma is safe to do and presently constitutes the only standard curative treatment for potentially resectable disease, it ultimately cures few patients. More... »

PAGES

122-125

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf02348736

DOI

http://dx.doi.org/10.1007/bf02348736

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1000331937


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "The Department of Surgery, New England Deaconess Hospital, Harvard Medical School, 110 Francis Street, Suite 3A, 02215, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Steele", 
        "givenName": "Glenn", 
        "id": "sg:person.0615647735.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0615647735.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Dana\u2013Farber Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.65499.37", 
          "name": [
            "Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mayer", 
        "givenName": "Robert J.", 
        "id": "sg:person.0607304430.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0607304430.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Emmes Corporation", 
          "id": "https://www.grid.ac/institutes/grid.280434.9", 
          "name": [
            "The EMMES Corporation, Potomac, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lindblad", 
        "givenName": "Anne", 
        "id": "sg:person.01147204635.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01147204635.30"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1001/archsurg.1984.01390180015003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013424480"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archsurg.1976.01360220026004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015242987"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ssu.2980090110", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020551701"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000658-198908000-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029529442"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000658-198908000-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029529442"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000658-198005000-00009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037582222"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000658-198005000-00009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037582222"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/01621459.1958.10501452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058299418"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1991.9.7.1105", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078157424"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079658535", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079802114", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082790157", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1995-06", 
    "datePublishedReg": "1995-06-01", 
    "description": "Single institution studies of hepatic resection have implied that some subsets of patients with metastases from colon and rectum adenocarcinoma can be cured by surgery. However, it is unknown how such patients can be selected and what, in fact, the ultimate cure rate is. The objective of this multi-institutional study was to define in a prospective manner how many patients predicted to have resectable liver metastases actually could undergo curative resection and what the disease-free and overall survival were. A prospective 15-institution treatment plan included all patients who were predicted to have resectable metastases from colon and rectum cancer primaries. Results were compared among patients who underwent successful resection, patients who underwent resection with pathologically defined inadequate margins, and patients who underwent exploration but were found at surgery not to have resectable liver metastases. Fourteen institutions throughout North America and one in Milan who were members of the Gastrointestinal Tumor Study Group at the inception of this protocol in July of 1984 participated in the study. The patient population consisted of all those with metachronous or synchronous metastases from colon or rectum adenocarcinoma seen during a consecutive 3 1/2 year period with protocol registry at the time liver metastases were predicted to be isolated and resectable. Intervention consisted of the application of standard preoperative screening tests, abdominal exploration, and resection of all patients who had liver-only surgically resectable disease. The main outcome measures were: Accuracy of preoperative staging, acute and chronic operative morbidity, and disease-free, as well as overall, survival among the three treatment groups. The minimum follow up on all surviving patiens after curative resection was 2.2 years, with a median follow up of 3.2 years. Median survival times for patients receiving curative and noncurative resections and for those receiving no resection were estimated to be 35.7, 21.2, and 16.5 months, respectively. No statistically significant difference in the survival distribution of the noncuratively resected or the non-resected patients was observed. The survival distribution of curatively resected patients remains statistically superior to the distribution of noncuratively resected patients and those receiving no resection (P=0.01). These results confirmed that, although liver resection for hepatic metastases from colorectal car cinoma is safe to do and presently constitutes the only standard curative treatment for potentially resectable disease, it ultimately cures few patients.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/bf02348736", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1043285", 
        "issn": [
          "1868-6974", 
          "1868-6982"
        ], 
        "name": "Journal of Hepato-Biliary-Pancreatic Sciences", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "2"
      }
    ], 
    "name": "A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Follow-up report", 
    "pagination": "122-125", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "0194575db586cb4634c0fbbfa9ad776f0af7ef18f4c79625a8a89a8d8db4e3e4"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf02348736"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1000331937"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf02348736", 
      "https://app.dimensions.ai/details/publication/pub.1000331937"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:56", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000365_0000000365/records_71673_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/BF02348736"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf02348736'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf02348736'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf02348736'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf02348736'


 

This table displays all metadata directly associated to this object as RDF triples.

107 TRIPLES      21 PREDICATES      37 URIs      19 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf02348736 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N06daba123fcf4fe7b1661b03c80ab844
4 schema:citation https://app.dimensions.ai/details/publication/pub.1079658535
5 https://app.dimensions.ai/details/publication/pub.1079802114
6 https://app.dimensions.ai/details/publication/pub.1082790157
7 https://doi.org/10.1001/archsurg.1976.01360220026004
8 https://doi.org/10.1001/archsurg.1984.01390180015003
9 https://doi.org/10.1002/ssu.2980090110
10 https://doi.org/10.1080/01621459.1958.10501452
11 https://doi.org/10.1097/00000658-198005000-00009
12 https://doi.org/10.1097/00000658-198908000-00001
13 https://doi.org/10.1200/jco.1991.9.7.1105
14 schema:datePublished 1995-06
15 schema:datePublishedReg 1995-06-01
16 schema:description Single institution studies of hepatic resection have implied that some subsets of patients with metastases from colon and rectum adenocarcinoma can be cured by surgery. However, it is unknown how such patients can be selected and what, in fact, the ultimate cure rate is. The objective of this multi-institutional study was to define in a prospective manner how many patients predicted to have resectable liver metastases actually could undergo curative resection and what the disease-free and overall survival were. A prospective 15-institution treatment plan included all patients who were predicted to have resectable metastases from colon and rectum cancer primaries. Results were compared among patients who underwent successful resection, patients who underwent resection with pathologically defined inadequate margins, and patients who underwent exploration but were found at surgery not to have resectable liver metastases. Fourteen institutions throughout North America and one in Milan who were members of the Gastrointestinal Tumor Study Group at the inception of this protocol in July of 1984 participated in the study. The patient population consisted of all those with metachronous or synchronous metastases from colon or rectum adenocarcinoma seen during a consecutive 3 1/2 year period with protocol registry at the time liver metastases were predicted to be isolated and resectable. Intervention consisted of the application of standard preoperative screening tests, abdominal exploration, and resection of all patients who had liver-only surgically resectable disease. The main outcome measures were: Accuracy of preoperative staging, acute and chronic operative morbidity, and disease-free, as well as overall, survival among the three treatment groups. The minimum follow up on all surviving patiens after curative resection was 2.2 years, with a median follow up of 3.2 years. Median survival times for patients receiving curative and noncurative resections and for those receiving no resection were estimated to be 35.7, 21.2, and 16.5 months, respectively. No statistically significant difference in the survival distribution of the noncuratively resected or the non-resected patients was observed. The survival distribution of curatively resected patients remains statistically superior to the distribution of noncuratively resected patients and those receiving no resection (P=0.01). These results confirmed that, although liver resection for hepatic metastases from colorectal car cinoma is safe to do and presently constitutes the only standard curative treatment for potentially resectable disease, it ultimately cures few patients.
17 schema:genre research_article
18 schema:inLanguage en
19 schema:isAccessibleForFree false
20 schema:isPartOf N6e610a4d137443dc96f29d5985fc9ff4
21 Nddc2596a61744bc2bb8bb07dde56720a
22 sg:journal.1043285
23 schema:name A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Follow-up report
24 schema:pagination 122-125
25 schema:productId N0c7dadef4d404cd186e26f10891c513b
26 N1b0c71a6c93f4dcbb87fcf2057d29083
27 Nb2729e1ebc6d47179b5534279e3b20da
28 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000331937
29 https://doi.org/10.1007/bf02348736
30 schema:sdDatePublished 2019-04-11T12:56
31 schema:sdLicense https://scigraph.springernature.com/explorer/license/
32 schema:sdPublisher N83f461aeb6ff4d09bacb6728706c6e74
33 schema:url http://link.springer.com/10.1007/BF02348736
34 sgo:license sg:explorer/license/
35 sgo:sdDataset articles
36 rdf:type schema:ScholarlyArticle
37 N06daba123fcf4fe7b1661b03c80ab844 rdf:first sg:person.0615647735.39
38 rdf:rest Nd8a0299109f2483db4f72da549ec28ab
39 N0bf30600158f4da181b49ca04e3e80f8 rdf:first sg:person.01147204635.30
40 rdf:rest rdf:nil
41 N0c7dadef4d404cd186e26f10891c513b schema:name readcube_id
42 schema:value 0194575db586cb4634c0fbbfa9ad776f0af7ef18f4c79625a8a89a8d8db4e3e4
43 rdf:type schema:PropertyValue
44 N1b0c71a6c93f4dcbb87fcf2057d29083 schema:name dimensions_id
45 schema:value pub.1000331937
46 rdf:type schema:PropertyValue
47 N6e610a4d137443dc96f29d5985fc9ff4 schema:volumeNumber 2
48 rdf:type schema:PublicationVolume
49 N83f461aeb6ff4d09bacb6728706c6e74 schema:name Springer Nature - SN SciGraph project
50 rdf:type schema:Organization
51 Nb2729e1ebc6d47179b5534279e3b20da schema:name doi
52 schema:value 10.1007/bf02348736
53 rdf:type schema:PropertyValue
54 Nd8a0299109f2483db4f72da549ec28ab rdf:first sg:person.0607304430.19
55 rdf:rest N0bf30600158f4da181b49ca04e3e80f8
56 Ndcaa5de6cff54cd485b52959163f6d2b schema:name The Department of Surgery, New England Deaconess Hospital, Harvard Medical School, 110 Francis Street, Suite 3A, 02215, Boston, MA, USA
57 rdf:type schema:Organization
58 Nddc2596a61744bc2bb8bb07dde56720a schema:issueNumber 2
59 rdf:type schema:PublicationIssue
60 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
61 schema:name Medical and Health Sciences
62 rdf:type schema:DefinedTerm
63 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
64 schema:name Clinical Sciences
65 rdf:type schema:DefinedTerm
66 sg:journal.1043285 schema:issn 1868-6974
67 1868-6982
68 schema:name Journal of Hepato-Biliary-Pancreatic Sciences
69 rdf:type schema:Periodical
70 sg:person.01147204635.30 schema:affiliation https://www.grid.ac/institutes/grid.280434.9
71 schema:familyName Lindblad
72 schema:givenName Anne
73 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01147204635.30
74 rdf:type schema:Person
75 sg:person.0607304430.19 schema:affiliation https://www.grid.ac/institutes/grid.65499.37
76 schema:familyName Mayer
77 schema:givenName Robert J.
78 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0607304430.19
79 rdf:type schema:Person
80 sg:person.0615647735.39 schema:affiliation Ndcaa5de6cff54cd485b52959163f6d2b
81 schema:familyName Steele
82 schema:givenName Glenn
83 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0615647735.39
84 rdf:type schema:Person
85 https://app.dimensions.ai/details/publication/pub.1079658535 schema:CreativeWork
86 https://app.dimensions.ai/details/publication/pub.1079802114 schema:CreativeWork
87 https://app.dimensions.ai/details/publication/pub.1082790157 schema:CreativeWork
88 https://doi.org/10.1001/archsurg.1976.01360220026004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015242987
89 rdf:type schema:CreativeWork
90 https://doi.org/10.1001/archsurg.1984.01390180015003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013424480
91 rdf:type schema:CreativeWork
92 https://doi.org/10.1002/ssu.2980090110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020551701
93 rdf:type schema:CreativeWork
94 https://doi.org/10.1080/01621459.1958.10501452 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058299418
95 rdf:type schema:CreativeWork
96 https://doi.org/10.1097/00000658-198005000-00009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037582222
97 rdf:type schema:CreativeWork
98 https://doi.org/10.1097/00000658-198908000-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029529442
99 rdf:type schema:CreativeWork
100 https://doi.org/10.1200/jco.1991.9.7.1105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078157424
101 rdf:type schema:CreativeWork
102 https://www.grid.ac/institutes/grid.280434.9 schema:alternateName Emmes Corporation
103 schema:name The EMMES Corporation, Potomac, MD, USA
104 rdf:type schema:Organization
105 https://www.grid.ac/institutes/grid.65499.37 schema:alternateName Dana–Farber Cancer Institute
106 schema:name Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
107 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...